Which blood cancers is intravenous carmustine indicated to treat?

Intravenous carmustine is indicated for palliation of multiple myeloma with a glucocorticoid, and Hodgkin’s disease or non-Hodgkin’s lymphomas as secondary therapy with other approved drugs after relapse during or failure of primary therapy; also for conditioning before autologous haematopoietic stem cell transplantation in Hodgkin/non-Hodgkin lymphoma.